retatrutide clinical trial stage for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational trials - Giblin - 2026 - Diabetes, Obesity and Metabolism Lilly's retatrutide delivers promising results
Description
PMID: 29033597
Picking the right injection site can make your weight loss journey smoother and more comfortable
Depending on the patient's blood glucose level, a 1-2 times daily injection regimen is available
Conclusion Dietary modification personalized to individual preferences and treatment goals (e.g., caloric deficits of 500 kcal/day), combined with structured physical activity (e.g., 150 minutes of moderate-to-vigorous exercise per week), produces additive benefits beyond GLP-1 therapy alone, enhancing weight loss, improving body composition, and reducing visceral fat and inflammation
